Results from the Adult Medication Study of the Restoring Insulin Secretion (RISE) clinical trial will be presented at 12:00 p.m. Sunday in S-157 (South, Upper Mezzanine Level). ADAMeetingNews.org asked RISE Consortium co-principal investigator Steven E. Kahn, MB, ChB, to discuss the background, objective, and significance of the study.
Beginning soon: Results and Comparisons from the RISE Clinical Trial—Adult Medication Study
